Doctor’s Doubts Imperil Lucrative Diabetes Drugs

Findings by Dr. Peter C. Butler on Merck’s medication Januvia are threatening the future of all drugs in its class, yearly sales of which exceed $9 billion.    

Source: NYT Health - May 30, 2013 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Butler, Peter C Pancreatic Cancer Drugs (Pharmaceuticals) Eli Lilly and Company LLY NYSE Merck & Company Inc MRK NYSE Diabetes Bristol Myers Squibb Company BMY NYSE Novo Nordisk A/S NVO NYSE Source Type: news